|
HCV: Explained 2018
(Preview)
I found this recent article on our favorite topic, HCV. I found it to be a good description of it and the many issues that accompany it. It’s easy to understand and could be a good tool for us to present when asked about the disease. See what you think. I give it a 9 out of 10... Everything You Need to Know: HCV...
|
Tig
|
0
|
1212
|
|
|
|
Shortening HCV Treatment Courses
(Preview)
From "Contagion Live - Infectious Diseases Today": ARTICLE Hepatitis C Treatment Time Could Be Cut in Half in Some Patients: A Proof of Concept Study NOV 14, 2018 | EINAV KEET A personalized medicine technique may shorten the duration and reduce the cost of treatment for hepatitis C virus infecti...
|
Canuck
|
0
|
1049
|
|
|
|
Organ Donors
(Preview)
http://time.com/4996657/heart-transplant-hepatitis-c/
|
dharmabum
|
5
|
2144
|
|
|
|
AASLD/IDSA release updated HCV treatment guidelines
(Preview)
The AASLD and IDSA HCV Guidance Panel has released updated guidelines for the treatment of hepatitis C virus infection, according to newly published data in Hepatology. You will note that they continue to recommend the use of 12 weeks of Sovaldi/Peg Interferon/Ribavirin in GT 3's that are able to...
|
Tig
|
1
|
2139
|
|
|
|
Liver Transplant Article
(Preview)
So, this article/take-home message, about the study (and the study itself) I found interesting - and, oh of course, they just had to study the costs savings! The part that was interesting to me was that group of liver transplant people who were studied and followed between 1998 and 2015, who WERE tole...
|
Canuck
|
0
|
888
|
|
|
|
A "new?" NS5A - "PP1-668" (Ravidasvir)
(Preview)
A relatively "new?" NS5A - (formerly called PP1-668), now named Ravidasvir. Well, it's news to me anyway. Out of Egypt (where there are many GT4's to trial it on), but reading other articles about it tonight, it IS being touted as pan, coupled with sof, with some impressive results, and more interest...
|
Canuck
|
11
|
5806
|
|
|
|
2011 HCV Blog News
(Preview)
https://hepatitiscnewdrugs.blogspot.com/2011/03/celebrities-with-hepatiti...
|
Canuck
|
0
|
946
|
|
|
|
Clinical Care Options: Tools for HCV Care
(Preview)
This slide set was published last year, but offers some interesting info for new and old members alike. I couldn’t locate it being brought here before and CCO is more often a physician only periodical most don’t have access to. It’s amazing to see the shear numbers affected by this disease globally an...
|
Tig
|
2
|
1342
|
|
|
|
SVR 24 Two Weeks After a Tripled Dose of Daclatasvir in an HCV Genotype 3 Patient
(Preview)
Thanks to the cultural mediator support, we explained to the patient the correct posology of each drug to take during the day consisting of 12 week SOF (400 mg daily) plus DCV (60 mg daily) regimen. He returned 13 days after for a programmed visit and we were surprised to learn that he had taken 3 pills o...
|
sleestak
|
3
|
1789
|
|
|
|
Extrahepatic Manifestation Improvements After SVR
(Preview)
From: MedscapeNews > Reuters Health InformationExtrahepatic Manifestations of Chronic Hep C Improve With Sustained Virological ResponseBy Will Boggs MDMay 21, 2018 NEW YORK (Reuters Health) - Extrahepatic manifestations of chronic hepatitis C virus (HCV) infection improve or res...
|
Canuck
|
1
|
1642
|
|
|
|
EASL 2018 Updates: Paris
(Preview)
EASL Paris 2018 Updates c/o Clinical Care Options - Hepatitis Review Capsules Summaries, download slides, and listen to audio commentary from expert-led Webinars covering critical studies on viral hepatitis and NAFLD/NASH from Paris. credit: Clinical Care Options
|
Tig
|
3
|
1706
|
|
|
|
Conquering Hep B/C via Micro-Elimination
(Preview)
Gilead, Inc., The World Health Organization has established a goal of eliminating viral hepatitis (hepatitis B and hepatitis C) by the year 2030.In support of this target, Gilead’s Medical Affairs team has created the CHIME Program (Conquering Hepatitis via Micro-Elimination), offering r...
|
Tig
|
0
|
1523
|
|
|
|
ALF CT Liver Transplant ReBirthday Party
(Preview)
YOU'RE INVITED!ALF CT Liver Transplant ReBirthday PartyApril is National Donate Life Month. The American Liver Foundation recognizes the incredible gift of life through transplantation.The Liver Tranplant ReBirthday Party is a gathering to hear liver transplantation updates from Con...
|
Tig
|
2
|
1901
|
|
|
|
Herpes Zoster Vaccination - "Shingrex" versus "Zostavax"
(Preview)
There was a fair bit of "talk" in the Journals, about safety profiles, and "Shingrex" getting approved for use over the "live" Zostavax in 2018. Between 2015 and as late as 2017 studies were still being completed about the effectiveness of Hep B and Zostavax immunizations in folk in association wit...
|
Canuck
|
5
|
2371
|
|
|
|
Viekirax and Exviera (OPrD) - Real World Data
(Preview)
Funny (not) how "real world" data takes so long to "come out"! Here is a recent publication (2018), all about "Viekirax" (ombitasvir/paritaprevir/ritonavir) and "Exviera" (dasabuvir) - also known as "OPrD" (similar to later and further formulations named Viekira Pak and then Viekira XR).B...
|
Canuck
|
2
|
1716
|
|
|
|
Hep C crosses the brain barrier
(Preview)
https://www.hepmag.com/article/HCV-Brain-Endothelium-21818-1287637502
|
skewedButNotBroken
|
4
|
1863
|
|
|
|
Harvoni SVR and then case of psoriasis remission
(Preview)
Published in Gastroenterology - News · January 18, 2018Psoriasis Remission Described After Hepatitis C Virus TreatmentCase report: After initiation of ledipasvir-sofosbuvir, HCV RNA decreased, and skin lesions improvedHealthDay WEDNESDAY, Jan. 17, 2018 (HealthDay News) -- A case of...
|
Canuck
|
3
|
1877
|
|
|
|
"Following" after SVR - Dr. Ira M. Jacobson
(Preview)
EDITORIAL - HCV Next, January/February - Dr. Ira M. JacobsonManaging the Fruits of HCV Cure: How Much Care do the Cured Need? The feature by Eric Lawitz, MD, very nicely encapsulates the revolutionary changes occurring within hepatitis C therapy over the past few years. As he explains, this ex...
|
Canuck
|
2
|
1309
|
|
|
|
Looking Back ... on HCV Treatment - Dr. Eric Lawitz
(Preview)
Helio - HCV Next, January/February - Eric Lawitz, MD COVER STORYLooking Back on an Unprecedented Revolution in Medicine As we conclude another year now past the peak of hepatitis C research, HCV Next asked me to consider where we came from, where we are now, and where we're headed. They wanted me...
|
Canuck
|
0
|
1263
|
|
|
|
The Unsung Heroes of HCV
(Preview)
Time to thank all of you that continue to make our forum the best it can be! We have thousands of you to thank for being there for each other through our journey. We are just one of the support groups that have made a difference. A tip of the hat to each of them! Unsung Heroes
|
Tig
|
8
|
2305
|
|
|
|
A "new?" NS5B - "AL-355"
(Preview)
Tig found and posted this very interesting one - it's aptly under "clinical trials", but I don't want to loose track of this new NS5B, so borrowed Tig's find to be over here as well, so it can be seen as new "news" as well! Hope that's OK Tig. Janssen 2a trial
|
Canuck
|
7
|
3268
|
|
|
|
Abby's - Pan 8 week Glec/Pib
(Preview)
News about Abby's Pan 8 week Glec (NS3/4A) and Pib (NS5A). No SOF. Especially intersting for those with compromized renal function, TN/TE/cirrhotics. They are stiving for shorter treatment times for these Pans. FDA grants priority review for AbbVie's pan-genotypic HCV regimen - February 3, 2...
|
Canuck
|
17
|
7923
|
|
|
|
HCV and Tainted Blood Product Inquiries/Studies
(Preview)
Hm, we have entered into this topic before ... what about those of us who, out of medical necessity and via deemed "best practices" of the times, received not transfusions per say, but various forms of "immunoglobulins" , see (U.K. Tainted Blood Inquiry), see (Viet Nam era veterans/ They gave us t...
|
Canuck
|
0
|
1058
|
|
|
|
Merck Drops Out
(Preview)
Looks like Merck is going after different markets and dropping out of the HCV drug business. Zepatier is their last. Not a bad finish! It has cured a lot of people. Merck‘s Out
|
Tig
|
6
|
2455
|
|
|
|
About Access to Sofa
(Preview)
Nonprofit challenges Gilead's patents on sofosbuvir October 27, 2017 - HelioInitiative for Medicines, Access & Knowledge - a U.S.-based nonprofit also known as I-MAK - filed a set of patent challenges against sofosbuvir, according to a press release from the organization. According to...
|
Canuck
|
1
|
1398
|
|
|
|
Hep C Hope - The Forgotten Virus
(Preview)
If you would like to educate yourself or have something to share with others, this organization has an informative website that will help. HepCHope Official Site
|
Tig
|
0
|
960
|
|
|
|
Trials - Hep B or Shingles Immunization - (if never immunized for these) and if you have HCV
(Preview)
-https://clinicaltrials.gov/ct2/show/record/NCT02429583
|
Canuck
|
0
|
903
|
|
|
|
Have your HBV immunity level checked if you have HCV or any other chronic liver disease state(s)
(Preview)
Updated ACIP Recommendations Nix LAIV, Expand HBV VaccinationDiana Swift - February 06, 2017 The final 2017 adult vaccination schedule has been issued by the Advisory Panel on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC).Published in the February 6...
|
Canuck
|
0
|
832
|
|
|
|
Fatty Liver Disease and Transplants in US Youth
(Preview)
Fatty Liver Disease Fastest-growing Reason for Transplants in Young U.S. Adults By Carolyn Crist - October 18, 2017(Reuters Health) - Nonalcoholic fatty liver disease and its more aggressive form, nonalcoholic steatohepatitis, have become the fastest-growing reasons for liver transplan...
|
Canuck
|
1
|
688
|
|
|
|
AASLD HCV Treatment Guideline Updates
(Preview)
Apparently they have recently inserted some updates, including recommendations for re-treating TE (treatment-experienced). https://www.hcvguidelines.org/
|
Canuck
|
0
|
775
|
|
|